Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yashma Patel"'
Autor:
Rosemary E. Gale, Neesa Bhudia, Kerry Wall, Frank McCaughan, Hassan Farah, Alan Kenneth Burnett, Michael A. Simpson, Jelena V. Jovanovic, Paresh Vyas, David Grimwade, Robert Kerrin Hills, Amanda F. Gilkes, Yashma Patel, Susanna Akiki, Ellen Solomon, Joanne Mason, Sylvie D. Freeman, David C. Linch, Adam Ivey, Angela Grech, Nigel H. Russell, Mike Griffiths
Publikováno v:
Ivey, A, Hills, R K, Simpson, M A, Jovanovic, J V, Gilkes, A, Grech, A, Patel, Y, Bhudia, N, Farah, H, Mason, J, Wall, K, Akiki, S, Griffiths, M, Solomon, E, McCaughan, F, Linch, D C, Gale, R E, Vyas, P, Freeman, S D, Russell, N, Burnett, A K & Grimwade, D 2016, ' Assessment of minimal residual disease in standard-risk AML ', New England Journal of Medicine, vol. 374, no. 5, pp. 422-433 . https://doi.org/10.1056/NEJMoa1507471
Despite the molecular heterogeneity of standard-risk acute myeloid leukemia (AML), treatment decisions are based on a limited number of molecular genetic markers and morphology-based assessment of remission. Sensitive detection of a leukemia-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba54f009593e6cccd0bc0f0861d20b4
https://kclpure.kcl.ac.uk/ws/files/46993158/nejmoa1507471.pdf
https://kclpure.kcl.ac.uk/ws/files/46993158/nejmoa1507471.pdf
Autor:
Mark E. Wagshul, Lauren B. Krupp, Yashma Patel, Hui Jing Yu, Dana Serafin, Mirjana Maletic-Savatic, Christopher Christodoulou, Vikram Bhise, Daniel Greenblatt
Publikováno v:
NeuroImage. 59:3713-3722
Diffusion tensor imaging (DTI) is a sensitive tool for detecting microstructural tissue damage in vivo. In this study, we investigated DTI abnormalities in individuals with relapsing remitting multiple sclerosis (RRMS) and examined the relations betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33a2179f4abe88a4408337d08b08005
https://doi.org/10.1016/j.neuroimage.2011.10.053
https://doi.org/10.1016/j.neuroimage.2011.10.053
Autor:
Kenneth Koo, Donald Milligan, Sarah Jenkinson, Keith Wheatley, Carol Guy, David C. Linch, Yashma Patel, Alan Kenneth Burnett, Claire Green, Archibald G. Prentice, Anthony H. Goldstone, Amanda F. Gilkes, Robert Kerrin Hills, Rosemary E. Gale
Publikováno v:
Blood. 115:948-956
We investigated the benefit of adding all-trans retinoic acid (ATRA) to chemotherapy for younger patients with nonacute promyelocytic acute myeloid leukemia and high-risk myelodysplastic syndrome, and considered interactions between treatment and mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af8f168d4c816594d97cf6ecb73227f
https://doi.org/10.1182/blood-2009-08-236588
https://doi.org/10.1182/blood-2009-08-236588
Publikováno v:
Clinical Neuroimmunology ISBN: 9781603278591
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::910f0b4f17b4910ede016a90e3d3623f
https://doi.org/10.1007/978-1-60327-860-7_8
https://doi.org/10.1007/978-1-60327-860-7_8
Publikováno v:
Annals of Indian Academy of Neurology
Annals of Indian Academy of Neurology, Vol 12, Iss 4, Pp 238-245 (2009)
Annals of Indian Academy of Neurology, Vol 12, Iss 4, Pp 238-245 (2009)
Pediatric multiple sclerosis (MS) represents a particular MS subgroup with unique diagnostic challenges and many unanswered questions. Due to the narrow window of environmental exposures and clinical disease expression, children with MS may represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d46606baa98f314e23b7c85f480230
https://pubmed.ncbi.nlm.nih.gov/20182571
https://pubmed.ncbi.nlm.nih.gov/20182571
Autor:
Kristian Rennie, Keith Wheatley, David Grimwade, Daniela Diverio, Robert Kerrin Hills, Richard E. Clark, Hannah Aslett, Katy Jones, Francesca Lo-Coco, Ellen Solomon, Roger Angell, Alan Kenneth Burnett, E. Nugent, Jelena V. Jovanovic, Yashma Patel, Rajinder Flora, Elaine Batson
Purpose Molecular diagnostics and early assessment of treatment response that use methodologies capable of detecting submicroscopic disease can distinguish subgroups of patients with leukemia at differing relapse risk. Such information is being incor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6895a61870419c6a3ffefca46bd0b559
http://hdl.handle.net/2108/8069
http://hdl.handle.net/2108/8069
Autor:
Rosemary E. Gale, Alan Kenneth Burnett, Claire Green, David T. Bowen, David C. Linch, Michael J. Groves, Yashma Patel, Robert Kerrin Hills, Christopher Allen
Publikováno v:
Leukemia. 23(1)
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39a6fec3dd6d6ef2797bd01ad2c3b08
https://pubmed.ncbi.nlm.nih.gov/18596741
https://pubmed.ncbi.nlm.nih.gov/18596741
Autor:
Nigel H. Russell, David Grimwade, Neesa Bhudia, Susanna Akiki, Rosemary E. Gale, Amanda F. Gilkes, Kerry Wall, Hassan Farah, Alan Kenneth Burnett, Sylvie D. Freeman, Frank McCaughan, Jelena V. Jovanovic, Paresh Vyas, Robert Kerrin Hills, Joanne Mason, Adam Ivey, Yashma Patel, Ellen Solomon, David C. Linch, Michael A. Simpson
Publikováno v:
Blood. 124:70-70
NPM1 mutation (NPM1c) defines the commonest molecular subtype of AML, which is molecularly heterogeneous, with outcome influenced by the pattern of cooperating mutations. This has generated interest in molecular profiling to guide treatment approach,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45b34e37e14bf72d0a8cb227c9a2c79f
https://doi.org/10.1182/blood.v124.21.70.70
https://doi.org/10.1182/blood.v124.21.70.70
Autor:
Amanda F. Gilkes, Keith Wheatley, Claire Green, Robert Kerrin Hills, Rosemary E. Gale, Michelle Lazenby, Alan Kenneth Burnett, Yashma Patel, David C. Linch
Publikováno v:
Blood. 112:554-554
Background: The prognostic value of mutations in NPM1 and FLT3-ITD is well known. Previously, Schlenk et al. (ASH 2007, Abstract 297) have reported that survival was significantly improved in a group of older patients who were NPM1 mutant/FLT3-ITD Wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c26dd64fa3b123ac72ef688de8415f7
https://doi.org/10.1182/blood.v112.11.554.554
https://doi.org/10.1182/blood.v112.11.554.554
Autor:
H. Aslett, Daniela Diverio, Yashma Patel, K. D. Jones, David Grimwade, Rajinder Flora, F. Lo Coco, Keith Wheatley, Alan Kenneth Burnett, Ellen Solomon, Robert Kerrin Hills, E Sellwood, E. Nugent, Jelena V. Jovanovic
Publikováno v:
Blood. 110:541-541
A key challenge in the management of APL is to improve upon survival rates now achieved with ATRA and anthracycline-based chemotherapy. One approach involves minimal residual disease (MRD) monitoring to identify patients otherwise destined to relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89f53284ba5386eca6f45d0d0aff9d26
https://doi.org/10.1182/blood.v110.11.541.541
https://doi.org/10.1182/blood.v110.11.541.541